Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Thytech logo — THYTECH is a health tech spin-off offering cellular therapy...

Thytech

THYTECH is a health tech spin-off offering cellular therapy for immune disorders, transplants, autoimmune diseases, and COVID.

Founded 2022 2-10 employees Pre Seed Total: $350.00K Health Care

General Information

Company Name Thytech
Founded Year 2022
Employees 2-10
Industries Health Care
Funding Stage Pre Seed
Social

Get notified when Thytech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Thytech

Thytech is a health tech startup that spun off from the Gregorio Marañón Health Research Institute (IISGM), specializing in cellular therapy for a range of health issues including immune disorders, transplants, autoimmune diseases, and COVID. Emerging from the Immunoregulation Laboratory's research, the company's patented thyTreg cell therapy holds potential in revolutionizing transplant rejection prevention and the treatment of autoimmune conditions, as well as COVID disease progression. Founded in 2022, Thytech recently secured a €350.00K Pre Seed Round investment on 11 April 2022, with prominent investors such as Banco Sabadell and GENESIS Biomed backing its innovative approach in the Health Care industry.

Taxonomy: health tech, cellular therapy, immune disorders, transplants, autoimmune diseases, COVID, patented technologies, thyTreg cell therapy, transplant rejection, immunological balance, childhood illnesses, Inmunología, Terapias Celulares avanzadas, Investigación Biomédica

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round •••••• 2
Investor
•••• •••• 		11 Apr 2022

Thytech Alternatives & Competitors

Thytech vs
Altum Health London
Altum Health London United Kingdom

Helping people with eating disorders and mental health struggles achieve meaningful change.

19 employees
Health Care, Health and Wellness
Thytech vs
Acticor Biotech
Acticor Biotech France

To treat the acute phase of ischemic stroke !

Post Ipo Equity
18 employees
Biopharma, Biotechnology
Thytech vs
Evo Health and Wellness
Evo Health and Wellness United States

Addiction treatment that respects where you are and where you want to go.

1 employees
Health Care

FAQ About Thytech

THYTECH is a health tech spin-off offering cellular therapy for immune disorders, transplants, autoimmune diseases, and COVID.
Thytech was founded in 2022.
Thytech operates in the following industries: Health Care.
Thytech has approximately 2-10 employees.
Thytech has completed 1 funding round, raising a total of $350.00K. The latest funding stage is Pre Seed.
Top alternatives and competitors to Thytech include Altum Health London, Acticor Biotech, Evo Health and Wellness, THE RESEARCH AND RECOGNITION PROJECT INC, Eudaemonia Equine Connections, Inc.®. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Thytech and Altum Health London are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Thytech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy